Hoba Therapeutics
PrivateLast Round
Series A
Dec 11, 2023
Total Funding Raised
$30.95M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Hoba Therapeutics is a biotechnology company that develops novel therapeutic proteins for the treatment of chronic neuropathic pain and sensorineural hearing loss.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Hoba Therapeutics Comparables
Compare Hoba Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| PharmNovo AB | 83% | |
| Algiax Pharmaceuticals | 78% | |
| Latigo Biotherapeutics | 78% |
Hoba Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Dec 11, 2023 | ||||
| Grant | Jun 16, 2021 | ||||
| Grant | Sep 20, 2018 | ||||
| Seed | Nov 1, 2016 |
Key People
Founding team and executive leadership
Hoba Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovation Fund Denmark | Grant |
| Medical Incubator Japan | Series A |
| Indaco Venture Partners SGR | Series A |
| Eir Ventures | Series A |
| Novo Holdings | Series A |
| The Export and Investment Fund of Denmark | Series A |
| Borean Innovation | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 580% MoM, from 40 to 272.
- Jul 3, 2025
Monthly visitors grew 371% MoM, from 255 to 1.2K.
Hoba Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Hoba Therapeutics's valuation, stock price, and market status.
Is Hoba Therapeutics a public or private company?
Hoba Therapeutics is a private company.
What is the current stock price of Hoba Therapeutics?
Hoba Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Hoba Therapeutics worth (valuation)?
Valuation information for Hoba Therapeutics is not publicly available.
Can I buy Hoba Therapeutics stock?
Hoba Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Hoba Therapeutics's last funding round?
Hoba Therapeutics's most recent funding round was Series A on December 11, 2023.
Who are the main investors in Hoba Therapeutics?
Key investors in Hoba Therapeutics include Innovation Fund Denmark, Medical Incubator Japan, Indaco Venture Partners SGR, European Innovation Council Fund.
Will Hoba Therapeutics IPO soon?
No public IPO plans have been announced for Hoba Therapeutics.
How can I track Hoba Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Hoba Therapeutics's secondary market activity and sign up for updates.